ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
HIV and hepatitis B and C in Latvia
At the request of the Ministry of Health in Riga, a team of experts from ECDC and the European Monitoring Centre for Drugs and Drug Addiction paid a technical visit to Latvia on 2–4 September 2014.
Technical mission: HIV in Cyprus, 15–17 October
The number of new HIV cases diagnosed annually in Cyprus has been on the rise since 2005: more than 50 new cases of HIV were diagnosed every year from 2011 to 2013. This report addresses this issue and provides options on how Cyprus can respond to the epidemic.
Communication strategies for the prevention of HIV, STI and hepatitis among MSM in Europe
This document provides guidance for developing innovative and effective communication strategies to promote a culture of lower risk behaviour in the MSM community in the European Union and European Economic Area.
Utilising social media for HIV/STI prevention programmes among young people
A handbook for public health programme managers working on STI/HIV prevention programmes for young people aged 15–24 years in EU/EEA countries.
Use of Twitter for HIV prevention among men who have sex with men in the European Union/European Economic Area
An ECDC guide to effective use of digital platforms for HIV prevention